Searched for
TAMSULOSIN
IPC issues alert on painkiller drug nimesulide over adverse reactionPharma standards body Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert over nimesulide, saying the pill can trigger ras...- Wockhardt shares climb 2% after USFDA makes nil observationIn a regulatory filing, the company said no observations were made after the US drug regulator inspected its Bioequivalence centre.
- Zydus Cadila gets USFDA nod for prostate condition treatment drugThe drug is used to treat symptoms of Benign Prostatic Hyperplasia (BPH) -- also called prostate gland enlargement.
- Wockhardt recalls over 50 lakh bottles of various drugs in USAs per the information available on the USFDA, Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
- Sun-Ranbaxy $4 billion merger completedSun Pharmaceutical Industries today said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals.
- Sun Pharma gets RBI nod for transfer of Ranbaxy's overseas investmentsThe central bank also approved issue of equity shares of Sun Pharma to the non-resident holders of equity shares of Ranbaxy Laboratories, t...
- Sun Pharma gets US FTC clearance for Ranbaxy acquisitionThe early termination of the waiting period under the HSR Act satisfies one of the essential conditions to the closing of the Ranbaxy acqui...
- US regulator imposes conditions on Sun Pharmaceuticals' Ranbaxy acquisitionTorrent Pharmaceuticals, a global drug company based in India that markets generic drugs in the United States, will acquire the divested as...
- CCI clears Sun-Ranbaxy merger deal with riders; asks two companies to divest some productsThe fair trade regulator's approval comes after the first ever public scrutiny carried out by it for a merger, which was announced in April.
- Aurobindo Pharma gets USFDA nod for two drugsAurobindo Pharma today said it has received final approvals from US health regulator to sell generic versions of two separate drugs.
- Sun Pharma gets USFDA nod for Flomax's generic versionSun Pharmaceutical Industries today said that it has received the US health regulator's nod to market a generic version of Flomax tamsulosi...
- Ranbaxy signs agreement with German insurance firmDrug major Ranbaxy Laboratories Ltd on Wednesday said its wholly-owned European subsidiary, Basics Gmbh has entered into an agreement with ...
- Ranbaxy in out-of-court deal for innovator drugRanbaxy Laboratories has reached an out-of-court settlement to market the generic copy of an innovator drug worth over $1 billion in the US.
- Ranbaxy receives nod for Tamsulosin Hydrochloride capsules in CanadaRanbaxy Laboratories has received approval to manufacture and market Tamsulosin Hydrochloride capsules in 0.4 mg strength from Health Canad...
- Ranbaxy, Astellas end patent rowRanbaxy Laboratories has reached an out-of-court settlement with Japanese company Astellas and Boehringer Ingelheim to sell Flomax, a drug ...
- Ranbaxy, Astellas, Boehringer reach deal over FlomaxRanbaxy Laboratories Ltd has reached an agreement with Astellas / Boehringer Ingelheim over Flomax (Tamsulosin capsules) patent.
- Ranbaxy gets tentative US nod for TamsulosinRanbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories, has received tentative approval from the U.S. Food a...
Load More
